(Q38056065)

27 August 2017

title

Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy (English)

1 reference

27 August 2017

0 references

Jong-Hee Kim

1

1 reference

27 August 2017

Hyo-Bum Kwak

series ordinal

2

1 reference

27 August 2017

LaDora V Thompson

series ordinal

3

1 reference

27 August 2017

John M Lawler

series ordinal

4

1 reference

27 August 2017

publication date

28 October 2012

1 reference

Journal of Muscle Research & Cell Motility

27 August 2017

published in

1 reference

27 August 2017

volume

34

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

1-13

1 reference

https://scigraph.springernature.com/pub.10.1007/s10974-012-9330-9

27 August 2017

exact match

0 references

cites work

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Calcium and the damage pathways in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The pathological damage in Duchenne muscular dystrophy may be due to increased intracellular OXY-radical generation caused by the absence of dystrophin and subsequent alterations in Ca2+ metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Eccentric contraction injury in dystrophic canine muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Integrin-mediated muscle cell spreading. The role of protein kinase c in outside-in and inside-out signaling and evidence of integrin cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin mutations predict cellular susceptibility to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Pharmacologic and genetic therapy for childhood muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Redox signaling across cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Caveolae and caveolin-3 in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The growing role of noninvasive ventilation in patients requiring prolonged mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Imatinib attenuates skeletal muscle dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Duchenne muscular dystrophy: survival by cardio-respiratory interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nitric oxide: biologic effects on muscle and role in muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nuclear factor-kappaB: its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin immunity in Duchenne's muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Association of neuronal nitric oxide synthase (nNOS) with alpha1-syntrophin at the sarcolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Animal models of muscular dystrophy – what can they teach us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Differential association of syntrophin pairs with the dystrophin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Oxidative stress and disuse muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Oxidative stress and the pathogenesis of muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Patients with dystrophinopathy show evidence of increased oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Treatment of Duchenne's muscular dystrophy with penicillamine. Results of a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Apoptosis of skeletal muscles during development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Increased catalase expression improves muscle function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Do immune cells promote the pathology of dystrophin-deficient myopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Drug trial of superoxide dismutase in Duchenne's muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The role of free radicals in the pathophysiology of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Compartmentalization of redox signaling through NADPH oxidase-derived ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

On the classification, natural history and treatment of the myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Targeting fibrosis in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Free radical generation by skeletal muscle of adult and old mice: effect of contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Duchenne muscular dystrophy

21 January 2018

1 reference

12 December 2020

Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state

1 reference

12 December 2020

Oxidative damage to muscle protein in Duchenne muscular dystrophy

1 reference

12 December 2020

Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse

1 reference

12 December 2020

Materials fatigue initiates eccentric contraction-induced injury in rat soleus muscle

1 reference

12 December 2020

Duchenne muscular dystrophy

1 reference

12 December 2020

Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E

1 reference

12 December 2020

Oxyradical damage and mitochondrial enzyme activities in the mdx mouse

1 reference

12 December 2020

Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old

1 reference

12 December 2020

Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice

1 reference

12 December 2020

Modulation of the dystrophin-associated protein complex in response to resistance training in young and older men

1 reference

12 December 2020

Markers of degeneration and regeneration in Duchenne muscular dystrophy

1 reference

12 December 2020

The capacity of mdx mouse diaphragm muscle to do oscillatory work

1 reference

12 December 2020

Clinical trial of high dosage vitamin E in human muscular dystrophy

1 reference

12 December 2020

The expression of alpha-dystrobrevin and dystrophin during skeletal muscle regeneration

1 reference

12 December 2020

Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells

1 reference

12 December 2020

Involvement of CAPON and nitric oxide synthases in rat muscle regeneration after peripheral nerve injury

1 reference

12 December 2020

Ultrastructural localization of alpha 1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relation to each other and to dystrophin

1 reference

12 December 2020

Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice

1 reference

12 December 2020

Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age.

1 reference

12 December 2020

Muscle cells from mdx mice have an increased susceptibility to oxidative stress

1 reference

12 December 2020

Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice

1 reference

12 December 2020

Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival

1 reference

12 December 2020

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

1 reference

12 December 2020

Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.

1 reference

12 December 2020

Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice

1 reference

12 December 2020

Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species

1 reference

12 December 2020

Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy

1 reference

12 December 2020

mdx muscle pathology is independent of nNOS perturbation

1 reference

12 December 2020

Curcumin alleviates dystrophic muscle pathology in mdx mice

1 reference

12 December 2020

Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.

1 reference

12 December 2020

Duchenne Muscular Dystrophy: Functional Ischemia Reproduces Its Characteristic Lesions

1 reference

12 December 2020

T-cell-dependent fibrosis in the mdx dystrophic mouse

1 reference

12 December 2020

Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy

1 reference

12 December 2020

Tocopherol Deficiency in Man

1 reference

12 December 2020

Amplification of proinflammatory phenotype, damage, and weakness by oxidative stress in the diaphragm muscle of mdx mice

1 reference

12 December 2020

1 reference

12 December 2020

Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice

1 reference

12 December 2020

10.1007/S10974-012-9330-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1038985211

0 references

1 reference